MEDICALLY REVIEWED

Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

ixekizumab (Taltz) plaque psoriasis

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Dr Francisco Salcido-Ochoa on ADPKD
Understanding Polycystic Kidney Disease: Guest Column by Dr Francisco Salcido-Ochoa

Autosomal Dominant Polycystic Kidney Disease, commonly referred to as ADPKD or simply Polycystic Kidney Disease, stands as a notable hereditary condition stemming from genetic mutations responsible for maintaining the intricate structure of our kidneys. While statistical prevalence varies globally, it is estimated that around 5 to 10 cases per 10,000 births are affected by this condition – a figure that places it within the realm of relatively common disorders.

Read More »